Literature DB >> 31279679

Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition).

Xiao Xu1, Jun Chen2, Qiang Wei2, Zhi-Kun Liu2, Zhe Yang2, Ming Zhang3, Guo-Ying Wang4, Jie Gao5, Zhao-Xu Yang6, Wen-Yuan Guo7, Tong-Hai Xing8, Zhou Shao2, Qin-Fen Xie9, Shu-Sen Zheng10.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31279679     DOI: 10.1016/j.hbpd.2019.06.010

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


× No keyword cloud information.
  9 in total

1.  Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation.

Authors:  Yinuo Li; Shosei Shimizu; Masashi Mizumoto; Takashi Iizumi; Haruko Numajiri; Hirokazu Makishima; Gong Li; Hideyuki Sakurai
Journal:  Cureus       Date:  2022-06-08

Review 2.  Exosomes as therapeutic vehicles in liver diseases.

Authors:  Jingyi Ding; Ju Wang; Jiajia Chen
Journal:  Ann Transl Med       Date:  2021-04

3.  Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database.

Authors:  Jie Zhou; Zhichao Huang; Zheng Chen; Fangshen Xu; Rongliang Tong; Shusen Zheng
Journal:  BMC Gastroenterol       Date:  2021-04-30       Impact factor: 3.067

Review 4.  The management of post-transplantation recurrence of hepatocellular carcinoma.

Authors:  Luckshi Rajendran; Tommy Ivanics; Marco Paw Claasen; Hala Muaddi; Gonzalo Sapisochin
Journal:  Clin Mol Hepatol       Date:  2021-10-05

5.  Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study.

Authors:  Tao Ouyang; Junxia Liu; Chengyang Shi; Lisheng Zhu; Xiaopeng Guo
Journal:  J Hepatocell Carcinoma       Date:  2021-11-26

6.  A novel biomarker NIFK-AS1 promotes hepatocellular carcinoma cell cycle progression through interaction with SRSF10.

Authors:  Huibin Song; Wenjing Li; Sixuan Guo; Zhentao He; Shi Liu; Yongsheng Duo
Journal:  J Gastrointest Oncol       Date:  2022-08

7.  An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist.

Authors:  Haiyang Chen; Meng Tao; Ding Li; Jing Han; Cheng Cheng; Yanfang Ma; Yingxi Wu; Vishal G Shelat; Francisco Tustumi; Sanjaya K Satapathy; Koo Jeong Kang; Qiming Wang
Journal:  Ann Transl Med       Date:  2021-06

8.  Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Authors:  Xuefeng Kan; Bin Liang; Guofeng Zhou; Bin Xiong; Feng Pan; Yanqiao Ren; Yanyan Cao; Jihua Wang; Fan Yang; Chuansheng Zheng
Journal:  Front Oncol       Date:  2020-07-07       Impact factor: 6.244

9.  Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.

Authors:  Hui He; Yawei Wang; Peng Ye; Dehui Yi; Ying Cheng; Haibo Tang; Zhi Zhu; Xun Wang; Shi Jin
Journal:  J Exp Clin Cancer Res       Date:  2020-08-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.